Important Safety Information: Tirzepatide with NAD+ and L-Carnitine | Compounded Injectable
What is this?
This Important Safety Information summarizes key warnings and precautions for Tirzepatide combined with NAD+ (nicotinamide adenine dinucleotide) and L-Carnitine in a compounded injectable formulation. Tirzepatide is a medication that acts on metabolic and glucose-regulating pathways and is used to support blood sugar control and metabolic health. NAD+ and L-Carnitine are included in some compounded formulations to support cellular energy metabolism and mitochondrial function.
This compounded injectable formulation has not been reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy. It should only be used exactly as directed by a licensed healthcare provider. This summary does not include all available information. Always read your medication label and follow your provider’s instructions.
Most Serious Warnings
Product can cause:
Possible risk of thyroid C-cell tumors. Tirzepatide has caused thyroid tumors in animals. It is not known if this occurs in humans. Report any neck mass, trouble swallowing, hoarseness, or difficulty breathing immediately.
Severe allergic reactions, including rash, swelling of the face or throat, wheezing, or difficulty breathing
Severe pancreatitis, which may present as intense abdominal or back pain with or without vomiting
Gallbladder problems, including upper right abdominal pain, fever, jaundice, or persistent nausea
Kidney problems, especially in the setting of dehydration
Severe low blood sugar when used with other diabetes medications
Dehydration leading to low blood pressure or worsening kidney function
Compounded formulations may carry sterility or formulation risks due to limited FDA oversight.
Who Should NOT Take Tirzepatide / NAD+ / L-Carnitine
Do not take this medication if you:
Have a personal or family history of medullary thyroid carcinoma
Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Have Type 1 diabetes
Have had pancreatitis unless cleared by your provider
Are allergic to tirzepatide or any component of the formulation
Are pregnant without direct medical supervision
Before Taking This Medication, Tell Your Healthcare Provider if You:
Have a history of thyroid disease
Have stomach or intestinal disorders
Have kidney disease
Have gallbladder disease
Have ever had pancreatitis
Take insulin or other medications that affect blood sugar
Take oral medications that may require timing adjustments
Use oral birth control pills
Drink alcohol regularly
Are pregnant, planning pregnancy, or breastfeeding
Take prescription, over the counter, or herbal supplements
Birth control pills may be less effective while using tirzepatide. Additional contraceptive measures may be required for 4 weeks after starting therapy and after each dose increase.
Possible Side Effects
Common (mild to moderate):
Nausea
Vomiting
Diarrhea
Constipation
Stomach pain
Decreased appetite
Heartburn
Injection site irritation
Serious (seek medical care immediately):
Signs of allergic reaction including swelling of face, lips, or throat
Severe abdominal pain or persistent vomiting
Symptoms of pancreatitis such as severe upper abdominal or back pain
Signs of gallbladder problems such as yellowing of skin or eyes
Signs of kidney problems such as decreased urination or swelling
Symptoms of low blood sugar including dizziness, shaking, confusion, sweating, or fast heartbeat
Persistent hoarseness, neck mass, or difficulty swallowing
While Taking Tirzepatide / NAD+ / L-Carnitine
Tell your healthcare provider immediately if you:
Develop severe abdominal pain
Experience persistent vomiting or dehydration
Notice changes in urination
Experience symptoms of low blood sugar
Develop neck swelling or voice changes
Experience vision changes or dizziness
Follow your prescribed diet and exercise plan. Monitor blood sugar as directed. Rotate injection sites with each dose. Do not share injection devices, even if needles are changed.
Pregnancy and Fertility
Tell your provider if you are pregnant, planning pregnancy, or breastfeeding. Risks and benefits must be discussed. Hormonal contraceptives taken by mouth may be less effective during treatment.
Overdose
Symptoms of overdose may include:
Severe nausea or vomiting
Severe low blood sugar
Dizziness or fainting
Severe abdominal pain
If overdose is suspected, seek emergency medical attention or contact Poison Control immediately.
Missed Dosage
If you miss a dose:
Take it as soon as remembered unless it is near the time of your next scheduled dose
Do not double the dose
Resume your regular weekly schedule as directed
Contact your provider if you are unsure how to proceed
Storage
Store as directed on your pharmacy label
Do not use if the solution appears cloudy, leaking, or contains particles
Do not freeze
Keep out of reach of children and pets
Medication Disposal
Dispose of used needles in an approved sharps container. Do not reuse needles. Dispose of unused or expired medication according to local guidelines.
Provider Oversight and Order Review
This compounded medication requires review and oversight by licensed Superior Health and Wellness providers. Dosing, titration, and ongoing therapy adjustments must be discussed directly with your provider to ensure safety and appropriateness. Orders may be modified based on labs, symptoms, and clinical response
Telemedicine Disclosure
This prescription may be issued via telemedicine. If you experience concerning or severe symptoms, contact your prescribing clinician immediately or seek emergency medical care.
Disclaimer
This summary does not include all information about tirzepatide, NAD+, and L-carnitine and should not replace medical guidance. Always consult your healthcare provider or pharmacist for complete safety information, potential interactions, and individualized treatment recommendations.
This compounded medication has not been evaluated or approved by the FDA for safety or efficacy.
You are encouraged to report negative side effects of prescription drugs to the FDA at www.fda.gov/medwatch or by calling 1-800-FDA-1088.
